BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghalib R, Levine C, Hassan M, McClelland T, Goss J, Stribling R, Seu P, Patt YZ. Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis. Hepatology. 2003;37:1165-1171. [PMID: 12717398 DOI: 10.1053/jhep.2003.50160] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA. Autologous Stem-Cell Transplantation Can Be Performed Safely Without the Use of Blood-Product Support. JCO 2004;22:4087-94. [DOI: 10.1200/jco.2004.01.144] [Cited by in Crossref: 38] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
2 Fontana RJ, Everson GT, Tuteja S, Vargas HE, Shiffman ML. Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis. Clinical Gastroenterology and Hepatology 2004;2:183-97. [DOI: 10.1016/s1542-3565(04)00002-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Trotter JF. Coagulation Abnormalities in Patients Who Have Liver Disease. Clinics in Liver Disease 2006;10:665-78. [DOI: 10.1016/j.cld.2006.08.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
4 Lawitz EJ, Hepburn MJ, Casey TJ. A Pilot Study of Interleukin-11 in Subjects with Chronic Hepatitis C and Advanced Liver Disease Nonresponsive to Antiviral Therapy. Am J Gastroenterology 2004;99:2359-64. [DOI: 10.1111/j.1572-0241.2004.40047.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
5 Thevenot T, Di Martino V, Lunel-fabiani F, Vanlemmens C, Becker M, Bronowicki J, Bresson-hadni S, Miguet J. Traitements complémentaires de l’hépatite chronique virale C. Gastroentérologie Clinique et Biologique 2006;30:197-214. [DOI: 10.1016/s0399-8320(06)73154-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Ciurea SO, Hoffman R. Cytokines for the Treatment of Thrombocytopenia. Seminars in Hematology 2007;44:166-82. [DOI: 10.1053/j.seminhematol.2007.04.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
7 Peeters K, Stassen J, Collen D, Van Geet C, Freson K. Emerging treatments for thrombocytopenia: Increasing platelet production. Drug Discovery Today 2008;13:798-806. [DOI: 10.1016/j.drudis.2008.06.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
8 Tillmann HL, McHutchison JG. Use of thrombopoietic agents for the thrombocytopenia of liver disease. Semin Hematol 2010;47:266-73. [PMID: 20620438 DOI: 10.1053/j.seminhematol.2010.04.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
9 Tan H, Dan G, Gong H, Cao L. Purification and Characterization of Recombinant Truncated Human Interleukin-11 Expressed as Fusion Protein in Escherichia coli. Biotechnol Lett 2005;27:905-10. [DOI: 10.1007/s10529-005-7179-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Giannini EG, Savarino V. Thrombocytopenia in liver disease: . Current Opinion in Hematology 2008;15:473-80. [DOI: 10.1097/moh.0b013e32830a9746] [Cited by in Crossref: 62] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
11 Guyader D. [How to treat non-responders to antiviral bitherapy for hepatitis C?]. Gastroenterol Clin Biol 2007;31:317-24. [PMID: 17396096 DOI: 10.1016/s0399-8320(07)89384-5] [Reference Citation Analysis]
12 Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D. Review article: Blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27:1017-1029. [PMID: 18331464 DOI: 10.1111/j.1365-2036.2008.03674.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 7.8] [Reference Citation Analysis]
13 Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther. 2006;23:1055-1065. [PMID: 16611265 DOI: 10.1111/j.1365-2036.2006.02889.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 8.3] [Reference Citation Analysis]
14 刘保文, 向慧玲, 梁静, 韩涛. 重组人白介素-11及重组人血小板生成素在治疗肝硬化脾功能亢进所致血小板减少的疗效对比. 世界华人消化杂志 2016; 24(34): 4608-4614 [DOI: 10.11569/wcjd.v24.i34.4608] [Reference Citation Analysis]
15 Laffi G, Tarquini R, Marra F. Thrombocytopenia in chronic liver disease: lessons from transplanted patients. J Hepatol 2007;47:625-9. [PMID: 17869369 DOI: 10.1016/j.jhep.2007.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
16 Negahdaripour M, Nezafat N, Ghasemi Y. A panoramic review and in silico analysis of IL-11 structure and function. Cytokine Growth Factor Rev 2016;32:41-61. [PMID: 27312790 DOI: 10.1016/j.cytogfr.2016.06.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
17 Tillmann HL, Patel K, McHutchison JG. Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C. Curr Gastroenterol Rep 2009;11:5-14. [PMID: 19166653 DOI: 10.1007/s11894-009-0002-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
18 Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: A review. World J Gastroenterol 2014; 20(10): 2595-2605 [PMID: 24627595 DOI: 10.3748/wjg.v20.i10.2595] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
19 Kobos R, Bussel JB. Overview of Thrombopoietic Agents in the Treatment of Thrombocytopenia. Clinical Lymphoma and Myeloma 2008;8:33-43. [DOI: 10.3816/clm.2008.n.002] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
20 Lotze MT, Herberman RB. Cancer as a chronic inflammatory disease: role of immunotherapy. In: Morgan DW, Forssmann UJ, Nakada MT, editors. Cancer and Inflammation. Basel: Birkhäuser; 2004. pp. 21-51. [DOI: 10.1007/978-3-0348-7861-6_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]